Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients
Observational Study to Assess the Health Status of Transplanted Patients (Kidney or Pancreas or Pancreatic Islet Transplantation) at Transplant Medicine Unit (MITRA) During the COVID-19 Pandemic
1 other identifier
observational
644
1 country
1
Brief Summary
Collect informations on the health status of transplanted patients (kidney, kidney / pancreas, pancreas or pancreatic islet) during the COVID-19 pandemic. All informations will be collected by short questionnaire via phone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2020
CompletedFirst Submitted
Initial submission to the registry
May 5, 2020
CompletedFirst Posted
Study publicly available on registry
May 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 18, 2020
CompletedJune 22, 2020
June 1, 2020
14 days
May 5, 2020
June 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Global Prevalence of COVID-19 TX
Global Prevalence of COVD-19 infection in transplanted patients
From 01st February 2020 to 18 May 2020
Hospitalization rate in COVID-19 TX
Hospitalization rate of transplanted patients
From 01st February 2020 to 18 May 2020
Secondary Outcomes (6)
Correlation COVID-19 TX and type of transplantation
From 01st February 2020 to 18 May 2020
Prevalence of COVID-19 TX in italian provinces
From 01st February 2020 to 18 May 2020
Symptoms in COVID-19 TX
From 01st February 2020 to 18 May 2020
Correlation COVID-19 TX and comorbidities
From 01st February 2020 to 18 May 2020
COVID-19 TX Therapies
From 01st February 2020 to 18 May 2020
- +1 more secondary outcomes
Study Arms (1)
Transplanted patients
Transplanted Kidney, Pancreas or Pancreatic Islet patients at MedicineTransplant Unit - San Raffaele Scientific Istitute
Interventions
Eligibility Criteria
Transplanted Kidney, Pancreas or Pancreatic Islet patients
You may qualify if:
- Transplanted Kidney or Kidney/Pancreas or Pancreas or Pancreatic Islet patients at Transplant Medicine Unit - San Raffaele Scientif Institute
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS San Raffaele
Milan, 20132, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio Secchi
IRCCS San Raffaele
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medicine Transplant Unit Director
Study Record Dates
First Submitted
May 5, 2020
First Posted
May 6, 2020
Study Start
May 4, 2020
Primary Completion
May 18, 2020
Study Completion
May 18, 2020
Last Updated
June 22, 2020
Record last verified: 2020-06